# Tesla, Inc. (TSLA) · Edgar & Edgarette company card

> Tesla (TSLA) saw revenue fall 2.9% in FY2025 to $94.8 billion, operating margin 4.6% against a -2.1% median for motor vehicles & passenger car bodies, equity 59.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1318605 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/TSLA) · [JSON](https://www.pops4.com/boards/company/TSLA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $94.8B |
| Revenue growth, 1 year | -2.9% |
| Revenue growth per year | 15.2% |
| Operating margin | 4.6% (prior year 7.2%) |
| Net margin | 4.1% |
| Operating cash flow | $14.7B |
| Capital spending | $8.5B |
| Free cash flow | $6.2B |
| Cash | $16.5B |
| Long-term debt | $6.6B |
| Total assets | $137.8B |
| Total equity | $82.1B |
| Equity ÷ assets | 59.6% |
| Return on equity | 4.7% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 4.46 (safe zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $94.8B (FY2025), total debt $6.6B. Experience: revenue down 2.9% on the year, up 15.2% a year over 4 years; operating margin 4.6%, down from 7.2%. Soundness: equity 59.6% of assets, return on equity 4.7%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $75.2B and $113.1B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $62.8B to $133.3B. A statistical range, not company guidance. Against peers (11 filers, $50M+ revenue, motor vehicles & passenger car bodies): operating margin 4.6% against a -2.1% median; growth -2.9% against -0.0%.

Range logged 2026-09-26, receipt 5c077c4823e794a6, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 10-Q · filed 2026-10-22 · [filing](https://www.sec.gov/Archives/edgar/data/1318605/000162828026066775/0001628280-26-066775-index.htm)
- 8-K · filed 2026-10-21 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1318605/000162828026066738/0001628280-26-066738-index.htm)
- DEF 14A · filed 2026-10-19 · [filing](https://www.sec.gov/Archives/edgar/data/1318605/000110465926116700/0001104659-26-116700-index.htm)
- 8-K · filed 2026-10-02 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1318605/000162828026064366/0001628280-26-064366-index.htm)
- 8-K · filed 2026-09-29 · 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1318605/000162828026063820/0001628280-26-063820-index.htm)
- 10-Q · filed 2026-07-23 · [filing](https://www.sec.gov/Archives/edgar/data/1318605/000162828026049270/0001628280-26-049270-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001318605.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1318605

## Cite

POPS4, Edgar & Edgarette: Tesla, Inc. (TSLA) company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/TSLA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

